Chemoinformaics analysis of Tricyclo[3.2.1.02,7]oct-3-ene, 2,3,4,5-tetramethyl-
| Molecular Weight | 162.276 | nRot | 0 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 10 |
| Exact Molecular Weight | 162.141 | nRing | 4 |
| Solubility: LogS | -4.596 | nHRing | 0 |
| Solubility: LogP | 4.037 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 32.0423 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.479 |
| Synth | 5.514 |
| Natural Product Likeliness | 1.184 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.022 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.611 |
| MDCK | 0.0000241 |
| BBB | 0.927 |
| PPB | 0.937383 |
| VDSS | 3.134 |
| FU | 0.0761377 |
| CYP1A2-inh | 0.288 |
| CYP1A2-sub | 0.583 |
| CYP2c19-inh | 0.285 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.192 |
| CYP2c9-sub | 0.753 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.683 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.303 |
| CL | 12.283 |
| T12 | 0.056 |
| hERG | 0.012 |
| Ames | 0.009 |
| ROA | 0.111 |
| SkinSen | 0.126 |
| Carcinogencity | 0.061 |
| EI | 0.936 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.036 |
| Antiviral | No |
| Prediction | 0.733875 |